Cargando…
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a
Nomegestrol acetate (NOMAC) has been successfully used for the treatment of some gynecological disorders, and as a combined oral contraceptive with approval in many countries. In this study, we investigated the effects of NOMAC on human endometrial cancer cells in vitro and in vivo. The proliferatio...
Autores principales: | Ma, A-ying, Xie, Shu-wu, Zhou, Jie-yun, Zhu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535830/ https://www.ncbi.nlm.nih.gov/pubmed/28640224 http://dx.doi.org/10.3390/ijms18071337 |
Ejemplares similares
-
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo
por: Cao, Can, et al.
Publicado: (2019) -
Nomegestrol acetate-17b-estradiol for oral contraception
por: Burke, Anne
Publicado: (2013) -
L-arginine enhances cell proliferation and reduces apoptosis in human endometrial RL95-2 cells
por: Greene, Jonathan M, et al.
Publicado: (2013) -
Expression of miR-106 in endometrial carcinoma RL95–2 cells and effect on proliferation and invasion of cancer cells
por: Li, Xingjun, et al.
Publicado: (2018) -
MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2
por: Xie, Wei, et al.
Publicado: (2016)